Showing results (21-30 of 55) with videos related to
Sort By:
Pageof 6
European Heart Journal Supplements : Journal of the European Society of Cardiology|June 29, 2026
Optimizing protected PCI strategies in the setting of chronic kidney disease and advanced coronary artery disease: a clinical case-based discussionMario Iannaccone, Jerzy Sacha, María Monteagudo-Vela, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 15, 2023
Clinical manifestations of cancer in patients with acute pulmonary embolismPiotr Feusette, Jerzy Sacha, Andrzej Tukiendorf, et al.Frontiers in Physiology|January 7, 2016
Interaction Between Heart Rate Variability and Heart Rate in Pediatric PopulationJakub S Gąsior, Jerzy Sacha, Piotr J Jeleń, et al.European Journal of Sport Science|February 16, 2021
Heart rate rather than heart rate variability is better associated with cardiorespiratory fitness in adultsAbel Plaza-Florido, Francisco J Amaro-Gahete, Francisco M Acosta, et al.Journal of Medical Systems|November 25, 2020
Cardiovascular Risk Factors and Heart Rate Variability: Impact of the Level of the Threshold-Based Artefact Correction Used to Process the Heart Rate Variability SignalAbel Plaza-Florido, J M A Alcantara, Francisco J Amaro-Gahete, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 17, 2022
Associations between heart rate variability and maximal fat oxidation in two different cohorts of healthy sedentary adultsAnabel González-Acedo, Abel Plaza-Florido, Francisco José Amaro-Gahete, et al.Polish Archives of Internal Medicine|January 2, 2025
Association between standardized management algorithm and outcomes of patients undergoing high-risk percutaneous coronary interventions included in the IMPELLA-PL registryAleksandra Gąsecka, Arkadiusz Pietrasik, Tomasz Pawłowski, et al.Scientific Reports|January 10, 2024
Percutaneous transaxillary approach through the first segment of the axillary artery for the Impella-supported PCI Versus TAVRJerzy Sacha, Krzysztof Krawczyk, Witold Gwóźdź, et al.European Heart Journal Supplements : Journal of the European Society of Cardiology|June 29, 2026
Optimizing revascularization in the high-risk heart: Impella™-facilitated percutaneous coronary intervention in multivessel coronary artery disease with reduced left ventricular ejection fraction and mitral regurgitationCristina Aurigemma, Jerzy Sacha, Pia Lanmüller, et al.ESC Heart Failure|June 22, 2023
Roadmap towards an institutional Impella programme for high-risk coronary interventionsArkadiusz Pietrasik, Aleksandra Gąsecka, Karolina Jasińska-Gniadzik, et al.Pageof 6